Skip to Main Content
header search
Search
Skip Nav Destination

Issues

Volume 6, Issue 4
November 2023
Issue Cover
ISSN 2666-2345
eISSN 2590-017X
Histiocytic Sarcoma Treated with Pembrolizumab: A Case Report and Literature Review
Daniel Huff; Shannon Fortin Ensign; Margaret S. Ryan; Jeanne Palmer; Javier Munoz
View Articletitled, Histiocytic Sarcoma Treated with Pembrolizumab: A Case Report and Literature Review
Open the PDF for in another window

RESEARCH ARTICLES

Evaluating Immune-Related Adverse Events Using PRO-CTCAE in a Phase II Study of Ipilimumab for Hormone-Sensitive Prostate Cancer
Daniel Vargas P. de Almeida; Justine M. Anderson; Daniel C. Danila; Michael J. Morris; Susan F. Slovin; Wassim Abida; Erica D. Cohn; Raymond E. Baser; Howard I. Scher; Karen A. Autio
View Articletitled, Evaluating Immune-Related Adverse Events Using PRO-CTCAE in a Phase II Study of Ipilimumab for Hormone-Sensitive Prostate Cancer
Supplementary data
Open the PDF for in another window
Mean Platelet Volume to Lymphocyte Ratio: A New Biomarker Predicting Response in Patients with Solid Tumors Treated with Nivolumab
Hasan Cagri Yildirim; Fatih Kus; Deniz Can Guven; Ece Karaca; Yunus Kaygusuz; Omer Dizdar; Sercan Aksoy; Mustafa Erman; Suayib Yalcin; Saadettin Kilickap
View Articletitled, Mean Platelet Volume to Lymphocyte Ratio: A New Biomarker Predicting Response in Patients with Solid Tumors Treated with Nivolumab
Open the PDF for in another window
Pulmonary Immune-Related Adverse Events of PD-1 Versus PD-L1 Checkpoint Inhibitors: A Retrospective Review of Pharmacovigilance
Ugochi Ebinama; Ajay Sheshadri; Kartik Anand; Iyer Swaminathan
View Articletitled, Pulmonary Immune-Related Adverse Events of PD-1 Versus PD-L1 Checkpoint Inhibitors: A Retrospective Review of Pharmacovigilance
Supplementary data
Open the PDF for in another window

LETTER TO THE EDITOR

Treatment for Advanced Non–Small Lung Cancer (NSCLC) with Mutated EGFR in Low- and Middle-Income Countries (LMICs)
Andrés F. Cardona; Vaneza Ávila; Oscar Arrieta
View Articletitled, Treatment for Advanced Non–Small Lung Cancer (NSCLC) with Mutated <em>EGFR</em> in Low- and Middle-Income Countries (LMICs)
Open the PDF for in another window

CASE REPORT

A Review of Scheduling Strategies for Radiotherapy and Immune Checkpoint Inhibition in Locally Advanced Rectal Cancer
Lydia Melissourgou-Syka; Michael A. Gillespie; Sean M. O'Cathail; Owen J. Sansom; Colin W. Steele; Campbell S. D. Roxburgh
View Articletitled, A Review of Scheduling Strategies for Radiotherapy and Immune Checkpoint Inhibition in Locally Advanced Rectal Cancer
Supplementary data
Open the PDF for in another window

ERRATUM

Erratum to “Sarcoidosis and Airway Disease After Immune Checkpoint Inhibitor Therapy: Case Study and Review of the Literature” by Soto et al
View Articletitled, Erratum to “Sarcoidosis and Airway Disease After Immune Checkpoint Inhibitor Therapy: Case Study and Review of the Literature” by Soto et al
Open the PDF for in another window

ACKNOWLEDGMENTS

Guest Editor and Reviewer Acknowledgments: 2023
View Articletitled, Guest Editor and Reviewer Acknowledgments: 2023
Open the PDF for in another window
All Issues
1 / 4
IPOF 2025 Call for Abstracts
2 / 4
JIPO is Now Indexed in ESCI
3 / 4
Editorial Services
4 / 4
Subscribe

  • eISSN 2590-017X
  • ISSN 2666-2345
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept